share_log

康哲藥業：翌日披露報表

CMS: Next Day Disclosure Return

香港交易所 ·  Apr 9 06:34
Summary by Moomoo AI
康哲藥業控股有限公司（CMS）於2024年4月9日提交了翌日披露報表，披露了公司股份購回的詳細情況。根據報表，公司在2024年4月2日至9日期間，通過香港聯合交易所購回了總計6,120,000股普通股，佔公司已發行股份的0.2496%。其中，4月9日單日購回了1,000,000股，每股價格介於HKD 7.59至HKD 7.7之間，當日總支付金額為HKD 7,636,600。公司確認，所有購回行為均已獲得董事會正式授權批准，並符合香港聯合交易所的相關規則。此外，公司已發行股本在購回後維持不變，為2,451,988,512股。
康哲藥業控股有限公司（CMS）於2024年4月9日提交了翌日披露報表，披露了公司股份購回的詳細情況。根據報表，公司在2024年4月2日至9日期間，通過香港聯合交易所購回了總計6,120,000股普通股，佔公司已發行股份的0.2496%。其中，4月9日單日購回了1,000,000股，每股價格介於HKD 7.59至HKD 7.7之間，當日總支付金額為HKD 7,636,600。公司確認，所有購回行為均已獲得董事會正式授權批准，並符合香港聯合交易所的相關規則。此外，公司已發行股本在購回後維持不變，為2,451,988,512股。
CONGE PHARMACEUTICAL HOLDINGS LIMITED (CMS) FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 9, 2024 DISCLOSING DETAILS OF THE COMPANY'S SHARE REPURCHASE. According to the report, the company repurchased a total of 6,120,000 shares of ordinary shares through the Hong Kong Stock Exchange between 2 and 9 April 2024, representing 0.2496% of the company's issued shares. Of these, 1,000,000 shares were repurchased on the single day of April 9, priced between HKD 7.59 and HKD 7.7, with a total payment on the day of HKD 7,636,600. THE COMPANY CONFIRMS THAT ALL REPURCHASES HAVE BEEN FORMALLY AUTHORISED BY THE BOARD OF DIRECTORS AND COMPLY WITH THE RELEVANT RULES OF THE HKEX. In addition, the company's issued share capital remained unchanged after the repurchase at 2,451,988,512 shares.
CONGE PHARMACEUTICAL HOLDINGS LIMITED (CMS) FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 9, 2024 DISCLOSING DETAILS OF THE COMPANY'S SHARE REPURCHASE. According to the report, the company repurchased a total of 6,120,000 shares of ordinary shares through the Hong Kong Stock Exchange between 2 and 9 April 2024, representing 0.2496% of the company's issued shares. Of these, 1,000,000 shares were repurchased on the single day of April 9, priced between HKD 7.59 and HKD 7.7, with a total payment on the day of HKD 7,636,600. THE COMPANY CONFIRMS THAT ALL REPURCHASES HAVE BEEN FORMALLY AUTHORISED BY THE BOARD OF DIRECTORS AND COMPLY WITH THE RELEVANT RULES OF THE HKEX. In addition, the company's issued share capital remained unchanged after the repurchase at 2,451,988,512 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more